Skip to content

Clinical trials

Completed Phase 4 Substance-Related Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Substance-Related Disorders Phase: Phase 4 Status: Completed Clear all

62 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20037
20046
20055
20071
20084
20094
20102
20123
20133
20143
20153
20161
20172
20183
20192
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Drug Abuse (NIDA)10
Yale University4
Creighton University3
Dartmouth-Hitchcock Medical Center3
Boston Medical Center2
Indivior Inc.2
Massachusetts General Hospital2
Medical University of South Carolina2
NYU Langone Health2
Oregon Health and Science University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Substance-Related Disorders62
Opioid-Related Disorders12
Alcoholism7
Attention Deficit Disorder with Hyperactivity7
Cocaine-Related Disorders7
Schizophrenia7
Psychotic Disorders6
Bipolar Disorder5
Acquired Immunodeficiency Syndrome4
Marijuana Abuse4

Trials

Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.